465 related articles for article (PubMed ID: 22634722)
21. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
Abboud RT; Ford GT; Chapman KR;
Can Respir J; 2001; 8(2):81-8. PubMed ID: 11320399
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19.
McElvaney OJ; McEvoy NL; Boland F; McElvaney OF; Hogan G; Donnelly K; Friel O; Browne E; Fraughen DD; Murphy MP; Clarke J; Choileáin ON; O'Connor E; McGuinness R; Boylan M; Kelly A; Hayden JC; Collins AM; Cullen A; Hyland D; Carroll TP; Geoghegan P; Laffey JG; Hennessy M; Martin-Loeches I; McElvaney NG; Curley GF
Med; 2022 Apr; 3(4):233-248.e6. PubMed ID: 35291694
[TBL] [Abstract][Full Text] [Related]
23. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
25. Delivery of Alpha-1 Antitrypsin to Airways.
Griese M; Scheuch G
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S346-51. PubMed ID: 27564672
[TBL] [Abstract][Full Text] [Related]
26. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
Parr DG; Lara B
Drug Des Devel Ther; 2017; 11():2149-2162. PubMed ID: 28769553
[TBL] [Abstract][Full Text] [Related]
28. A review of α1-antitrypsin deficiency.
Stoller JK; Aboussouan LS
Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
[TBL] [Abstract][Full Text] [Related]
29. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
Zuo L; Pannell BK; Zhou T; Chuang CC
Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
[TBL] [Abstract][Full Text] [Related]
30. α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in Macrophages.
Bai X; Bai A; Tomasicchio M; Hagman JR; Buckle AM; Gupta A; Kadiyala V; Bevers S; Serban KA; Kim K; Feng Z; Spendier K; Hagen G; Fornis L; Griffith DE; Dzieciatkowska M; Sandhaus RA; Gerber AN; Chan ED
J Immunol; 2022 Nov; 209(9):1746-1759. PubMed ID: 36162872
[TBL] [Abstract][Full Text] [Related]
31. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.
Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA
Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011
[No Abstract] [Full Text] [Related]
32. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
33. Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice.
Ostermann L; Maus R; Stolper J; Schütte L; Katsarou K; Tumpara S; Pich A; Mueller C; Janciauskiene S; Welte T; Maus UA
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554955
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology and treatment of alpha 1-antitrypsin deficiency.
MacDonald JL; Johnson CE
Am J Health Syst Pharm; 1995 Mar; 52(5):481-9;quiz 544-5. PubMed ID: 7606551
[TBL] [Abstract][Full Text] [Related]
35. Alpha-1-antitrypsin and other proteinase inhibitors.
Miravitlles M
Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
[TBL] [Abstract][Full Text] [Related]
36. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.
Joosten LA; Crişan TO; Azam T; Cleophas MC; Koenders MI; van de Veerdonk FL; Netea MG; Kim S; Dinarello CA
Ann Rheum Dis; 2016 Jun; 75(6):1219-27. PubMed ID: 26174021
[TBL] [Abstract][Full Text] [Related]
37. Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.
Lee S; Lee Y; Hong K; Hong J; Bae S; Choi J; Jhun H; Kwak A; Kim E; Jo S; Dinarello CA; Kim S
Mol Med; 2013 May; 19(1):65-71. PubMed ID: 23552726
[TBL] [Abstract][Full Text] [Related]
38. α-1-antitrypsin inhibits acute liver failure in mice.
Jedicke N; Struever N; Aggrawal N; Welte T; Manns MP; Malek NP; Zender L; Janciauskiene S; Wuestefeld T
Hepatology; 2014 Jun; 59(6):2299-308. PubMed ID: 24449466
[TBL] [Abstract][Full Text] [Related]
39. Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity.
Reeves EP; Dunlea DM; McQuillan K; O'Dwyer CA; Carroll TP; Saldova R; Akepati PR; Wormald MR; McElvaney OJ; Shutchaidat V; Henry M; Meleady P; Keenan J; Liberti DC; Kotton DN; Rudd PM; Wilson AA; McElvaney NG
J Immunol; 2019 Apr; 202(8):2240-2253. PubMed ID: 30796179
[TBL] [Abstract][Full Text] [Related]
40. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
Bergin DA; Hurley K; McElvaney NG; Reeves EP
Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):81-97. PubMed ID: 22349104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
